Percutaneous transthoracic biopsies are commonly performed for the diagnosis of thoracic lesions. Early reports of needle biopsies of the lung were published in the late 1800s.1–2 In 1883, Leyden1– biopsied the consolidated right lower lobe of a moribund 48-year-old man. The specimen was stained, and bacteria and WBCs were identified. Pneumonia was diagnosed, unfortunately, the patient died 1 day later. Menetrier2– described a 51-year-old man who presented on May 25, 1885, with a productive cough, fever, and physical examination findings positive at the left base. On July 14, 150 mL pus was extracted via a needle, and the organism was identified as Streptococcus pyogenes. The patient died on October 19 of that year. Autopsy showed an organized left pleural empyema with no malignancy. Since then, needle biopsy has gained wide acceptance for diagnosing malignant and benign lung lesions. The common modalities employed in the guidance of percutaneous lung biopsy are fluoroscopy and CT scanning. Since the advent of CT scanning, fluoroscopic guidance has been utilized less often, and CT scanning and CT scan-fluoroscopic guidance dominate the current literature. Ultrasound guidance can be used for the biopsy of subpleural lesions.3 However, the use of ultrasound as an imaging modality for guiding lung biopsies has not been widely adopted.